|
Volumn 17, Issue 1, 2017, Pages 296-299
|
Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus—United States, May 2013–August 2016
a b a a a a,c c c c d d e e f f f f f f g more.. |
Author keywords
[No Author keywords available]
|
Indexed keywords
AMPHOTERICIN B LIPID COMPLEX;
ANTIFUNGAL AGENT;
ECHINOCANDIN;
FLUCONAZOLE;
BLOODSTREAM INFECTION;
CANDIDA;
CANDIDA AURIS;
CANDIDA AURIS INFECTION;
CANDIDA FAMATA;
CANDIDA HAEMULONII;
CANDIDEMIA;
CANDIDIASIS;
CENTRAL VENOUS CATHETER;
CLINICAL LABORATORY;
DNA SEQUENCE;
EDITORIAL;
FUNGAL COLONIZATION;
FUNGUS CULTURE;
FUNGUS ISOLATION;
HUMAN;
INFECTION CONTROL;
MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY;
MINIMUM INHIBITORY CONCENTRATION;
MULTIDRUG RESISTANCE;
NONHUMAN;
PATHOGEN CLEARANCE;
PRIORITY JOURNAL;
PUBLIC HEALTH SERVICE;
RHODOTORULA GLUTINIS;
SACCHAROMYCES CEREVISIAE;
SOUTH AMERICA;
SOUTH ASIA;
UNITED STATES;
URINARY CATHETER;
WHOLE GENOME SEQUENCING;
COMMUNICABLE DISEASE;
DRUG EFFECTS;
GLOBAL HEALTH;
ISOLATION AND PURIFICATION;
MICROBIOLOGY;
PROGNOSIS;
RISK FACTOR;
TIME FACTOR;
ANTIFUNGAL AGENTS;
CANDIDA;
CANDIDIASIS;
COMMUNICABLE DISEASES, EMERGING;
DRUG RESISTANCE, MULTIPLE, FUNGAL;
GLOBAL HEALTH;
HUMANS;
PROGNOSIS;
RISK FACTORS;
TIME FACTORS;
UNITED STATES;
|
EID: 85008946269
PISSN: 16006135
EISSN: 16006143
Source Type: Journal
DOI: 10.1111/ajt.14121 Document Type: Editorial |
Times cited : (172)
|
References (10)
|